REV1 and infection: Regarding Rev1, the infection kinetics of this vaccine were evaluated upon inoculation of 4 ± 1-day-pregnant mice (via IP with 6–7 × 105 CFU/mouse; Table 1) in a recent publication by Poveda-Urkixo et al. [73].